Trials / Completed
CompletedNCT00358475
Study Of Perennial Allergic Rhinitis
Study of Perennial Allergic Rhinitis -Long Term Treatment Study-
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GW685698 |
Timeline
- Start date
- 2005-06-21
- Primary completion
- 2005-10-01
- Completion
- 2005-10-12
- First posted
- 2006-07-31
- Last updated
- 2018-08-31
Source: ClinicalTrials.gov record NCT00358475. Inclusion in this directory is not an endorsement.